Table 4

 Comparison of lung function and C-reactive protein (CRP) levels between rhinovirus, Bordetella pertussis, Chlamydia pneumoniae positive and negative asthma patients

NFEV1(l/s)FEV1 (% predicted)FEV1/FVC (%)FEV1/FVC (% predicted)CRP (mg/l)
Median(range)Median difference(95% CI)Median(range)Median difference(95% CI)Median(range)Median difference(95% CI)Median(range)Median difference(95% CI)Median(range)Median difference(95% CI)
CI, confidence interval; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity.
*Mann-Whitney U test, two tailed asymptomatic significance.
†Statistically significant.
Rhinovirus
    Positive132.79 (2.03–3.57)−0.23 (−0.61 to 0.18)79 (58–111)−10.0 (−18.0 to −2.0)80.5 (72.0–88.3)1.0 (−2.3 to 4.3)98 (82–105)1.0 (−3.5 to 5.0)3.31 (0.86–12.11)1.04 (−0.18 to 2.75)
    Negative903.03 (1.59–5.52)93.5 (40–130)80.0 (47.6–91.4)97 (67–110)1.96 (0.01–24.41)
    p value*0.2430.020‡0.5680.6510.092
B pertussis
    Positive252.93 (1.69–5.47)−0.05 (−0.38 to 0.31)93 (40–127)0.0 (−8.0 to 8.0)78.4 (47.6–87.9)−2.5 (−5.5 to 0.5)95 (67–109)−2.0 (−6.1 to 2.0)2.21 (0.07–24.41)0.35 (−0.59 to 1.37)
    Negative782.99 (1.59–5.52)92 (57–130)80.4 (60.2–91.4)97 (72–110)2.07 (0.01–19.65)
    p value*0.8380.9260.1050.30.472
C pneumoniae
    Positive222.94 (1.81–4.41)0.03 (−0.32 to 0.35)89 (58–127)−4.0 (−11.0 to 4.0)78.2 (61.2–89.5)−3.5 (−6.1 to −0.4)94 (74–110)−3.9 (−7.0 to 0.0)2.47 (0.07–7.31)−0.17 (−1.09 to 0.94)
    Negative812.94 (1.59–5.54)92 (40–130)80.8 (47.6–91.4)98 (67–110)2.01 (0.01–24.41)
    p value*0.8880.3760.023†0.041†0.815